What You Ought to Know
- The Elevate: Frist Cressey Ventures (FCV) has closed an oversubscribed $425M Fund IV, bringing its whole belongings below administration to almost $1 billion.
- The Technique: The brand new fund will concentrate on early-stage healthcare corporations reworking care supply, with a selected emphasis on AI-native enterprise fashions and tech-enabled companies.
- The “Moat”: FCV’s strategic Restricted Companions (LPs)—together with The Cigna Group, MedStar Well being, and OhioHealth—present healthcare to over 50% of the U.S. inhabitants, giving portfolio corporations an enormous benefit in distribution and pilots.
Strategic Benefit
FCV has constructed a syndicate of strategic companions—together with The Cigna Group Ventures, MedStar Health, and OhioHealth—that collectively contact greater than 50% of the U.S. inhabitants.
For a startup founder, that is the distinction between a examine and a buyer.
- 25% of FCV’s portfolio corporations have secured funding from at the very least one among these strategic companions.
- The Cigna Group explicitly famous that the collaboration helps them “advance options that drive higher well being outcomes.”
FCV made its title investing in value-based care fashions (like Thyme Care). Fund IV will proceed that work however is aggressively increasing into “AI-native enterprise fashions.”
FCV Profitable Observe Report
The agency is getting into its second decade with a scorecard that validates its “policy-plus-capital” method.
- Efficiency: Fund I and Fund II rank within the prime 5% of all enterprise capital funds for his or her respective vintages.
- Exits: The agency has notched 14 profitable exits out of 44 whole investments.
“This milestone displays the readability of function, conviction, and deep dedication of our group, buyers, and portfolio corporations, all united by a shared mission to advance innovation in healthcare that improves lives and retains sufferers on the heart of every part we do,” stated Sen. Invoice Frist, MD, Co-Founder and Managing Accomplice, Frist Cressey Ventures. “As we enter this subsequent chapter, we’re excited to construct robust, transformative, and enduring partnerships – and to function a trusted associate to the leaders and corporations shaping the way forward for patient-centered care.”
